DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia Formula F1 Papaverine 1.8 mg/mL Phentolamine 0.2 recall — FDA D-0927-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 95
10,685 detailed records are currently available in this category.
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia Myers Cocktail, Magnesium Chloride 9.65 mg/mL recall — FDA D-0938-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia QM-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL recall — FDA D-0947-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia Amino Blend Glutamine 30 mg/mL Ornithine HCL 50 recall — FDA D-0949-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Preferred Pharmaceuticals Losartan Potassium & HCTZ Tablets 50mg/12.5 mg recall — FDA D-0891-2022
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIFDA: TerminatedPreferred Pharmaceuticals, Inc.
DrugJun 1, 2022
Olympia Mineral Blend Magnesium Chloride 80 mg/mL Zinc Sulfate 1 mg/mL Manganese Sulfate 20 recall — FDA D-0941-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia Testosterone Cypionate 200 mg/mL in Sesame Oil recall — FDA D-0912-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized recall — FDA D-0939-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Olympia Compounding Pharmacy dba Olympia Lipo-Mino-Mix Pyridoxine HCL (B6) 2 mg/mL recall — FDA D-0932-2022
Lack of assurance of sterility.
Class IIFDA: CompletedOlympia Compounding Pharmacy dba Olympia Pharmacy
DrugJun 1, 2022
Preferred Pharmaceuticals Losartan Potassium & HCTZ Tablets 50mg/12.5 mg recall — FDA D-0892-2022
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class IIFDA: TerminatedPreferred Pharmaceuticals, Inc.
DrugMay 25, 2022
American Health Packaging Nitrofurantoin Capsules, USP recall — FDA D-0880-2022
Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
Class IIIFDA: TerminatedAmerican Health Packaging
DrugMay 25, 2022
Bestco Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint recall — FDA D-0879-2022
Subpotent drug: Low OOS for menthol content at the three month room temperature.
Class IIIFDA: TerminatedBestco LLC
DrugMay 25, 2022
Plastikon Healthcare Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone recall — FDA D-0868-2022
Microbial Contamination of Non-Sterile Products
Class IFDA: CompletedPlastikon Healthcare LLC
DrugMay 25, 2022
Plastikon Healthcare MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup recall — FDA D-0867-2022
Microbial Contamination of Non-Sterile Products
Class IFDA: CompletedPlastikon Healthcare LLC
DrugMay 25, 2022
Plastikon Healthcare Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup recall — FDA D-0869-2022
CGMP Deviations: Failure to properly investigate failed microbial testing.
Class IIFDA: CompletedPlastikon Healthcare LLC
DrugMay 25, 2022
Plastikon Healthcare Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone recall — FDA D-0871-2022
CGMP Deviations: Failure to properly investigate failed microbial testing.
Class IIFDA: CompletedPlastikon Healthcare LLC
DrugMay 25, 2022
Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens recall — FDA D-0882-2022
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Class IFDA: CompletedCardinal Health Inc.
DrugMay 25, 2022
Plastikon Healthcare MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup recall — FDA D-0870-2022
CGMP Deviations: Failure to properly investigate failed microbial testing.
Class IIFDA: CompletedPlastikon Healthcare LLC
DrugMay 25, 2022
Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle recall — FDA D-0881-2022
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
Class IIIFDA: TerminatedApotex Corp.
DrugMay 18, 2022
Lula Holdings Kill 'Dat Sanitizing Products Hand Sanitizer, 1 gallon (128 fl. oz.) 80% recall — FDA D-0859-2022
CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.
Class IIFDA: TerminatedLula Holdings LLC
DrugMay 18, 2022
Mylan Institutional Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg recall — FDA D-0860-2022
Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Class IIFDA: TerminatedMylan Institutional, Inc. (d.b.a. UDL Laboratories)
DrugMay 18, 2022
Viatris Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle recall — FDA D-0854-2022
Failed Dissolution Specifications: low out of specification results for dissolution.
Class IIFDA: TerminatedViatris Inc.
DrugMay 18, 2022
buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle recall — FDA D-0858-2022
Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister…
Class IIIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugMay 18, 2022
buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg recall — FDA D-0857-2022
Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister…
Class IIIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.